Publisher’s Platform: Fifty People Sick, A Known Supplier, And FDA Still Won’t Say Its Name. That Is Wrong, And Here Is How We Fix It.

TL;DR

Before you orderOffer from Amazon

Get kitchen staples and gadgets delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

Food Safety News reports that 50 people were sickened in a multistate E. coli O157:H7 outbreak being investigated by FDA and USDA, with a chicken wrap identified as suspect. Its publisher says federal agencies have not publicly named the retailer or manufacturer and has prepared two citizen petitions seeking clearer disclosure rules; the petitions have not yet been filed.

Fifty people have been sickened in a multistate outbreak of E. coli O157:H7 that FDA and USDA’s Food Safety and Inspection Service are investigating, according to a Food Safety News publisher’s account. The publisher says the public federal investigation table identifies only a “multi-ingredient wrap with chicken (suspect),” without naming the product’s retailer or manufacturer, and is urging FDA to adopt rules requiring disclosure.

The account identifies the product as Trader Joe’s Tarragon Chicken Salad Wraps. It says that information became public through a federal lawsuit filed on October 15, 2026, rather than through an announcement by FDA or FSIS. The source, which is written by a lawyer involved in the litigation, identifies F&S Fresh Foods of Vineland, New Jersey as the manufacturer for Trader Joe’s, based on what the author says they learned in the case. The agencies have not publicly confirmed those identifications in the material provided.

The author says federal investigators know the product and retailer, have entered the supply chain and collected receipts, and have genetic sequencing evidence linking illnesses. The account does not provide the outbreak’s affected states, hospitalization count, individual illness dates, or the specific ingredient suspected of contamination. It also says no recall, public advisory, or public health alert has been issued. Those details are the author’s description of the investigation; the supplied material does not include agency statements independently confirming them.

The account attributes the lack of public naming to the agencies’ position that company identities are confidential commercial information unless a recall is attached. It says the wraps were “proactively removed from the market” and were past shelf life, but that the action was not classified as a recall. The author argues that tying disclosure to the label “recall” can leave consumers without firm or distribution information when food is removed under another description.

Why Supplier Disclosure Matters

Identifying a supplier can help consumers, retailers and public health officials determine whether other products or distribution channels may be affected. The publisher says the agencies have not disclosed whether a contaminated ingredient could have entered other products made by F&S Fresh Foods for other retailers. That question is not answered in the source material.

The dispute also concerns how the public can evaluate an outbreak investigation. When agencies identify only a broad food description, people may have difficulty recognizing a product they bought or understanding whether related foods are implicated. At the same time, public identification can carry consequences for a firm, particularly if the evidence is incomplete or later changes. The proposed approach described by the author would pair disclosure with a chance for a firm to correct factual errors and a public correction if it is later cleared.

The author’s argument is that a written, consistently applied standard would make disclosure less dependent on whether an action is called a recall, withdrawal or proactive removal. That is the author’s policy position, not a statement that FDA has accepted the proposal.

Past Outbreaks and Agency Naming

To support the call for a rule, the publisher lists previous investigations in which agencies named farms, processors or brands after products were no longer on sale or beyond their shelf life. The examples cited include a 2006 Dole spinach outbreak, several 2018 romaine investigations, 2021 salad and spinach cases, and a 2022 strawberry outbreak. These examples are presented by the author to argue that expired shelf life has not always prevented public identification.

The account also compares the current investigation with a 2013 E. coli outbreak involving chicken salads made by Glass Onion Catering and sold at Trader Joe’s. It says CDC named the companies and FSIS published a recall listing the products. The author argues that the current case is comparable because it involves the same retailer, a similar type of product and the same E. coli strain designation. The comparison is the publisher’s; the supplied source does not include agency records for each earlier case.

As another example, the author cites an FSIS public health alert in May 2026 that named The Kebab Shop restaurants and a beef kofta producer even though the product had been made months earlier. The piece contrasts those disclosures with unnamed produce investigations, arguing that agency practice is inconsistent. Its central claim is that the presence or absence of a recall has influenced whether firms were named.

Key Facts Still Not Public

The outbreak’s full scope remains unclear from the supplied account. It gives a total of 50 people sickened but not the states involved, illness timeline, number hospitalized, or whether anyone has died. It does not identify the ingredient believed to be contaminated or explain whether investigators have established a confirmed source.

The account identifies the wraps and F&S Fresh Foods through the author’s description of information learned in litigation, but it does not include public confirmation from FDA or FSIS. The agencies’ current evidence, the basis for withholding names, and whether the implicated ingredient appears in other products are also not detailed in agency statements here. The author says two petitions are prepared, but neither has been filed, so the proposed language and any agency response remain pending.

Petitions Await Public Review

The author says two companion citizen petitions have been prepared for FDA but are not yet filed, because the author wants more people to review them first. The first, titled “Outbreak Firm Disclosure,” would ask FDA to adopt a rule through notice-and-comment procedures. As described in the source, it would make a firm’s name and location disclosable when epidemiological evidence implicates a food and traceback or laboratory evidence points to the firm.

The proposed petition would also apply disclosure requirements when implicated food is removed from commerce, regardless of whether the action is called a recall, market withdrawal, stock recovery or proactive removal, and regardless of shelf life. It would place the burden on a firm seeking secrecy to show a genuine trade secret, provide a business day to correct factual errors, and require a prominent correction if a firm named publicly is later cleared.

The source says there is a second companion petition but does not provide its title or full contents in the material available. The next stated step is review before filing. No filing date, FDA response, or timeline for a rulemaking is given. The outbreak investigation is described as ongoing, and the supplied material does not state whether agencies plan to issue a public alert or name additional firms.

Key Questions

What product is linked to the outbreak?

The source article identifies Trader Joe’s Tarragon Chicken Salad Wraps as the suspected product. It says the public investigation table described it only as a “multi-ingredient wrap with chicken (suspect).”

How many people have been sickened?

The account reports 50 people sickened with E. coli O157:H7 in a multistate outbreak. It does not provide the affected states or hospitalization count.

Who does the publisher identify as the manufacturer?

The author identifies F&S Fresh Foods of Vineland, New Jersey, as the manufacturer for Trader Joe’s, based on information the author says was learned in litigation. The supplied material does not include public confirmation of that identification from FDA or FSIS.

Have the proposed FDA petitions been filed?

No. The author says the two companion citizen petitions are prepared but not yet filed, pending further review. The source does not give a filing date.

What information remains unknown?

The supplied account does not state the affected states, hospitalization count, illness dates, suspected contaminated ingredient, or whether related products may be affected. It also does not include a public agency confirmation of the named product or manufacturer.

Source: rss